← Back to Search

Behavioral Intervention

Cancer Screening Methods for Colorectal and Liver Cancer (GTI Trial)

N/A

Waitlist Available

Led By Shari S Rogal, MD, MPH

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Providers: ≥18 years of age

Be older than 18 years old

Must not have

Veterans: <18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to compare two methods of increasing cancer testing rates for gastrointestinal cancers like colon and liver cancer. The study will look at whether it is more effective to directly reach out to people who need testing

Who is the study for?

This trial is for veterans who may be at risk of gastrointestinal cancers, such as colon or liver cancer. It's designed to find better ways to increase cancer screening rates among this group.

What is being tested?

The study compares two methods to boost cancer screenings: direct outreach to patients and support for providers to overcome barriers in the testing process. The effectiveness will be measured by changes in screening rates.

What are the potential side effects?

Since this trial focuses on improving screening processes rather than testing new medications, there are no direct side effects from interventions like drugs. However, participants might experience inconvenience or anxiety related to increased engagement with healthcare services.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am a veteran and under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Reach of CRC screening from Baseline to 12 months

Change in Reach of HCC screening from Baseline to 12 months

Secondary study objectives

Acceptability assessed by the Acceptability of Intervention Measure (AIM)

Appropriateness assessed by the Intervention Appropriateness Measure (IAM)

Change in Adoption of screening from Baseline to 12 months

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Patient Navigation (PN)Active Control1 Intervention

Half of the HCC sites and half of the CRC sites will be randomized to PN delivered by Clinical Resource Hub navigators.

Group II: Implementation Facilitation (IF)Active Control1 Intervention

Half of the HCC sites and half of the CRC sites will be randomized to IF delivered by 2 facilitators (one clinical and one evaluation expert) per site.

0 / 2Eligibility criteria met